Cancer
Advertisement
Case reports suggest that GLP-1 receptor agonists may impact FDG PET scan image quality.
Thirty percent of myeloma lytic bone lesions are not detected via FGD PET, demonstrating the need for improved visualization.
REASSURE assessed the long-term safety of radium-223, an alpha-emitting calcium mimetic that targets bone metastases.
Childhood cancer survivors had a 2.6-fold higher risk of mortality after breast cancer recurrence.
Patients in the Northeast showed the highest age-adjusted cardiovascular mortality rate.
Black patients had the lower distant-stage 5-year overall survival compared with White and Asian patients.
Definitive evidence that structured exercise programs substantially improve survival outcomes for colon cancer patients
Differences in the use of targeted therapies between Black and White patients decreased between 2010-2011 and 2018-2019.
Dr. Erin Dickman discusses oncology nurses' pivotal role in patient breast cancer survivorship and lymphedema management.
"PD-L1 inhibitors have significantly changed oncology [but] only about 30% of patients with cancer benefit from the drugs."
Hurricane Maria's impact led to delays in care and uncertainty for patients with cancer in Puerto Rico.
Dr. Andrew Hertler explains the FDA’s decision to narrow approvals for PD-1 inhibitors for stomach and esophageal cancers
Potential microbial culprit behind the alarming rise in early-onset colorectal cancer: a bacterial toxin called colibactin.
Factors such as long travel times to access care or limited parking options were reported as barriers to care.
Dr. Bruce Dorr on what menopausal women with BRCA should know about hormone replacement therapy.
Florida's demographics reflect what the US population could look like in the future in terms of aging and diversity.
Gastric cancer represents one of America's most pronounced cancer disparities, with incidence rates 2 to 13 times higher.
Patients with LIS subsidies were less likely to receive any systemic therapy compared with patients not receiving subsidies.
Dr. Alessandra Maleddu discusses desmoid tumor, improving patient diagnosis and seeing a sarcoma specialist
Researchers identified several socioeconomic and logistic barriers that limit diversity in clinical trials.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.